95 related articles for article (PubMed ID: 12787726)
1. Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense.
Minko T; Dharap SS; Fabbricatore AT
Cancer Detect Prev; 2003; 27(3):193-202. PubMed ID: 12787726
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.
Dharap SS; Qiu B; Williams GC; Sinko P; Stein S; Minko T
J Control Release; 2003 Aug; 91(1-2):61-73. PubMed ID: 12932638
[TBL] [Abstract][Full Text] [Related]
3. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.
Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T
J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.
Pakunlu RI; Cook TJ; Minko T
Pharm Res; 2003 Mar; 20(3):351-9. PubMed ID: 12669953
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system.
Pakunlu RI; Wang Y; Tsao W; Pozharov V; Cook TJ; Minko T
Cancer Res; 2004 Sep; 64(17):6214-24. PubMed ID: 15342407
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
7. Targeted proapoptotic LHRH-BH3 peptide.
Dharap SS; Minko T
Pharm Res; 2003 Jun; 20(6):889-96. PubMed ID: 12817893
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Bax-induced cytochrome c release from neural cell and brain mitochondria by dibucaine and propranolol.
Polster BM; Basañez G; Young M; Suzuki M; Fiskum G
J Neurosci; 2003 Apr; 23(7):2735-43. PubMed ID: 12684459
[TBL] [Abstract][Full Text] [Related]
9. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
Kuwana T; Bouchier-Hayes L; Chipuk JE; Bonzon C; Sullivan BA; Green DR; Newmeyer DD
Mol Cell; 2005 Feb; 17(4):525-35. PubMed ID: 15721256
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.
Certo M; Del Gaizo Moore V; Nishino M; Wei G; Korsmeyer S; Armstrong SA; Letai A
Cancer Cell; 2006 May; 9(5):351-65. PubMed ID: 16697956
[TBL] [Abstract][Full Text] [Related]
11. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L).
Vieira HL; Boya P; Cohen I; El Hamel C; Haouzi D; Druillenec S; Belzacq AS; Brenner C; Roques B; Kroemer G
Oncogene; 2002 Mar; 21(13):1963-77. PubMed ID: 11960369
[TBL] [Abstract][Full Text] [Related]
12. Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.
Minko T; Kopecková P; Kopecek J
J Control Release; 2001 Apr; 71(3):227-37. PubMed ID: 11295216
[TBL] [Abstract][Full Text] [Related]
13. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
14. Regulation of apoptosis by BH3 domains in a cell-free system.
Cosulich SC; Worrall V; Hedge PJ; Green S; Clarke PR
Curr Biol; 1997 Dec; 7(12):913-20. PubMed ID: 9382837
[TBL] [Abstract][Full Text] [Related]
15. [BH3 mimetics as a strategy to complement anticancer therapies].
Hartman MŁ; Czyż M
Postepy Hig Med Dosw (Online); 2012 Feb; 66():67-77. PubMed ID: 22371408
[TBL] [Abstract][Full Text] [Related]
16. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
Hsu SY; Lin P; Hsueh AJ
Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
[TBL] [Abstract][Full Text] [Related]
17. BIRO1, a cell-permeable BH3 peptide, promotes mitochondrial fragmentation and death of retinoblastoma cells.
Allaman-Pillet N; Oberson A; Schorderet DF
Mol Cancer Res; 2015 Jan; 13(1):86-97. PubMed ID: 25143432
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis.
Tsang WP; Chau SP; Kong SK; Fung KP; Kwok TT
Life Sci; 2003 Sep; 73(16):2047-58. PubMed ID: 12899928
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the antiapoptotic protein Nr-13 and cytochrome c. Antagonistic effect of the BH3 domain of Bax.
Moradi-Améli M; Lorca T; Ficheux D; di Pietro A; Gillet G
Biochemistry; 2002 Jul; 41(27):8540-50. PubMed ID: 12093270
[TBL] [Abstract][Full Text] [Related]
20. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
